4The Multidisciplinary Sign-off and the Final Plan

FWho sits at the table

The cochlear implant team is a structured multidisciplinary collaboration — surgeon (ENT), audiologist, hearing therapist, speech-language pathologist, clinical psychologist, teacher of the deaf and social worker — with clear role delineation so each profession contributes specialised expertise while sharing responsibility for the decision. The hearing therapist runs functional hearing assessment (live-voice testing, lipreading, communication skills), counsels on realistic expectations and arranges meetings with existing implant users; the speech-language therapist assesses voice, speech perception, language comprehension and intelligibility and co-designs the rehabilitation package with audiology. The clinical psychologist evaluates motivation and psychological candidacy, screens for depression or psychiatric disorder that could affect outcome, and identifies learning disability or multiple handicap that might impair understanding and informed consent — a step recommended by FDA guidance. Effective teams need defined values and standards, a demonstrated chain of responsibility, consistent clinical procedures and openness to external scrutiny; a balanced mix of action-, people- and cerebral-oriented team roles lets the team achieve more than the sum of its members.[2006][2006][2006][2006]

CThe pre-operative pathway into the case conference

The pathway runs in a systematic sequence: referral, team meeting to determine fit, core audiological assessment, functional (live-voice) hearing testing, speech and language assessment, psychological assessment, optional specialised tests (OAE/SSEP, vestibular, genetic, promontory/round-window stimulation), ENT decision with CT/MRI imaging review, then pre-implant consultation before theatre. Medical sign-off requires a complete evaluation by the surgical team confirming the patient is fit for elective surgery under general anaesthesia, with any condition needing specialised management or contraindicating surgery identified; active respiratory infection, fever or instability mandates postponement, and a medically stable patient is a prerequisite. Paediatric candidates need extra scrutiny — a 12-lead ECG screens for Jervell and Lange-Nielsen syndrome (prolonged QT, risk of Torsade de Pointes under anaesthesia, requiring beta-blockade), experienced paediatric anaesthesia is mandatory, and imaging findings such as a wide vestibular aqueduct (possible Pendred syndrome) prompt paediatric referral before proceeding. BCIG/NICE candidacy criteria (severe-to-profound loss, thresholds greater than 90 dB HL at 2 and 4 kHz in the better ear, BKB sentence score 50% or less in quiet) are the audiological gate the conference confirms before sign-off.[2006][2006][2019][2006]

CConfirming the ear and the device

Ear selection for unilateral implantation is driven by shorter duration of deafness, higher residual speech discrimination and favourable anatomy; in bilateral candidates the ear with better residual discrimination or shorter deafness duration typically takes priority to optimise speech outcome. The conference must confirm the patient understands that residual hearing in the implanted ear may be lost and that loss is irreversible — hearing aids cannot be reverted to if implantation disappoints; modern soft-surgery preserves some residual hearing in about 92% (50% complete, 42% partial), but it declines to roughly 69% retained at 12 or more months. Cochlear ossification (e.g. post-meningitic labyrinthitis ossificans, which can begin 3 to 21 days after meningitis) and inner-ear malformations limit electrode insertion depth and can change which ear or device is chosen — urgent implantation is advised before ossification precludes insertion. Device choice considers anatomy, etiology and feature needs; the team also weighs CSF-gusher risk (about 1% overall, higher with incomplete partition or enlarged cochlear aperture) which shapes both electrode selection and the intraoperative plan.[2006][2019][2016][2025]

CChecklists, vaccination and documentation before theatre

Pneumococcal vaccination is a hard pre-operative requirement: implant recipients carry a 138-fold elevated incidence of pneumococcal meningitis, and CDC/ACIP advise PCV plus PPSV23 given at least 2 weeks before surgery (8 weeks between doses; interval shortened to 8 weeks if immunocompromised or with CSF leak), with Hib vaccine added for children under 5 years. A nurse or nurse practitioner should own vaccination oversight — monthly review of records for vaccination status, direct administration and documented confirmation fed back to the surgical team; a structured quality-improvement program raised paediatric pre-op pneumococcal coverage from 67% to 98%. Documented informed consent must record the specific risk frequencies discussed: facial-nerve stimulation 2.9 to 5.3% (up to about 15% in otosclerosis), facial palsy 0.67 to 1.2%, vestibular dysfunction (caloric abnormality about 49% at 14 months, though 74% report no handicap), taste disturbance about 45%, and post-implant meningitis about 0.7%. Final documentation before theatre captures the confirmed ear and device, completed medical and anaesthetic clearance, imaging review, vaccination confirmation, signed consent recording realistic expectations and the family or caregiver commitment to long-term rehabilitation — only then is the case signed off.[2003][2003][2018][2018][2021][2007]